Guildford, United Kingdom

David B Horrobin

This inventor holds 1 USPTO granted patent. Top assignee: Scarista Limited. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David B Horrobin. Retrieved from https://idiyas.com/inventor/david-b-horrobin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David B Horrobin: Innovator in Drug Delivery Systems

Introduction

David B Horrobin is a notable inventor based in Guildford, GB. He has made significant contributions to the field of drug delivery through his innovative research and development. His work focuses on creating compounds that enhance the efficacy of drug delivery systems.

Latest Patents

David B Horrobin holds a patent for 1,3-propane diol esters and ethers and methods for their use in drug delivery. This invention relates to compounds of a specific formula, wherein R is selected from fatty acid acyl groups of 12 to 30 carbon atoms and fatty alcohol groups of 12 to 30 carbon atoms. The compounds are designed to deliver drugs and other bioactive compounds effectively.

Career Highlights

Throughout his career, David has been associated with Scarista Limited, where he has applied his expertise in drug delivery systems. His innovative approach has led to advancements in the pharmaceutical industry, particularly in the formulation of drug delivery methods.

Collaborations

David collaborates with professionals such as Sherri Clarkson, who serves as a Legal Representative, and Mehar Manku. These collaborations enhance the development and application of his inventions in the industry.

Conclusion

David B Horrobin is a prominent figure in the field of drug delivery, with a focus on innovative compounds that improve the effectiveness of pharmaceuticals. His contributions continue to influence advancements in drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…